Furthermore, blockade of S100A9 can reduce the infiltration and activation of neutrophil and prevent sepsis-related pulmonary edema and tissue damage, suggesting that S100A9 may be a key target for alleviating sepsis-related injury (39). The gene discussed is S100A9; the disease is Sepsis.